Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide on Lung Function in Type 2 Diabetes Mellitus
NCT02889510Phase 3Completed
- Start
- Oct 2016
- Primary completion
- Nov 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM). Started Oct 2016; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02889510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889510.